<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Recce completes cohort dosing for Phase I/II UTI/Urosepsis Rapid Infusion Clinical Trial with fastest infusion times yet; key safety review inbound	</title>
	<atom:link href="https://www.recce.com.au/recce-completes-cohort-dosing-for-phase-i-ii-uti-urosepsis-rapid-infusion-clinical-trial-with-fastest-infusion-times-yet-key-safety-review-inbound/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.recce.com.au/recce-completes-cohort-dosing-for-phase-i-ii-uti-urosepsis-rapid-infusion-clinical-trial-with-fastest-infusion-times-yet-key-safety-review-inbound/</link>
	<description>Recce</description>
	<lastBuildDate>Wed, 25 Sep 2024 00:26:35 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>
</channel>
</rss>
